Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01075 is a member of the long intergenic non-coding RNA (lincRNA) family, defined as RNA transcripts longer than 200 nucleotides that do not overlap coding genes, and generally function as regulators of gene expression, often through changes in chromatin structure or transcription modulation. LINC01075 may have tissue-specific regulatory roles, as observed in lincRNAs, and genome-wide studies have associated genetic variation in this locus with end-stage kidney disease, suggesting a potential but uncharacterized functional contribution in renal pathology. However, no specific molecular or functional characterization of LINC01075 has been described, and it is not known to interact with drugs or act as a biomarker.
None established for drugs (no drugs reported)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1075 (LINC01075).